|
|
Volumn 6, Issue 9, 2000, Pages 951-955
|
|
Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CD4 ANTIGEN;
CD8 ANTIGEN;
DRUG VEHICLE;
GLYCOPROTEIN GP 120;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
VACCINIA VACCINE;
ARTICLE;
CELLULAR IMMUNITY;
CLINICAL RESEARCH;
CLINICAL TRIAL;
CYTOTOXIC T LYMPHOCYTE;
DRUG DELIVERY SYSTEM;
DRUG DESIGN;
DRUG MECHANISM;
DRUG POTENCY;
HELPER CELL;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
KENYA;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
VACCINE PRODUCTION;
VACCINIA VIRUS;
VIRUS ATTENUATION;
VIRUS GENE;
AIDS VACCINES;
AMINO ACID SEQUENCE;
CLINICAL TRIALS;
DRUG DESIGN;
HIV INFECTIONS;
HIV-1;
HUMAN;
KENYA;
MOLECULAR SEQUENCE DATA;
SUPPORT, NON-U.S. GOV'T;
VACCINES, DNA;
VACCINES, SYNTHETIC;
VACCINIA VIRUS;
|
|
EID: 0033826855
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/79626 Document Type: Article |
|
Times cited : (190)
|
|
References (0)
|
